Shape the Future of Neural Technology
Aika Lab is building the foundational layer for closed-loop neuromodulation. We are selectively open to strategic investors and partners who share our long-term vision for human performance optimization through neuroscience.
Company Snapshot
Technology Moats
Proprietary Neurodynamics Computational Model
A parametric, real-time model of EEG oscillatory dynamics built from first principles and validated against clinical PSG. Not available in open literature.
Closed-Loop Neuroacoustic Stimulation (CLAS) Algorithm
Phase-locked acoustic stimulation targeting slow-wave UP states with sub-50ms loop latency. Core IP with pending patent protection. Demonstrated 15–30% SWA improvement in pilots.
Multi-Modal BCI Signal Processing Pipeline
Hardware-agnostic signal processing that operates across consumer EEG, research EEG, and fNIRS — enabling a platform business model.
Full-Stack Capability: Research to Product
Unique position covering the full value chain — from neuroscience research to SDK, from algorithm to consumer application — without external dependencies.
Market Opportunity
Global BCI Market
Projected 2030 market size
Source: IDTechEx estimates, 2026Sleep Health Market
Global consumer + clinical sleep technology
Source: Grand View Research estimates, 2026Adults with Sleep Disorders
Report sleep quality issues in developed markets
Source: WHO / NSF, 2026 estimatesHow We Partner
Equity Investment
Direct equity stake in Aika Lab. Suitable for seed through Series A stage investors with strategic value-add in neurotechnology, digital health, or consumer hardware.
Contact IR →Strategic Alliance
Commercial partnerships with revenue sharing or cross-licensing arrangements. Suitable for hardware companies, health platforms, and distribution partners.
Discuss a partnership →Joint Lab
Co-funded R&D laboratory arrangement with shared IP ownership and publication rights. Suitable for academic institutions and corporate R&D centers.
Explore joint lab →Frequently Asked Questions
What stage is Aika Lab currently at?
We are at Seed / Pre-Series A stage. We have a working product, paying early partners, and are raising to accelerate algorithm R&D, clinical validation, and SDK distribution.
Is Aika Lab open to strategic investors only, or also financial investors?
We prioritize strategic investors who bring distribution, clinical access, or hardware integration value. We are selective about pure financial investors at this stage.
How do I request the investor data room?
Email hello@aikalab.se with a brief introduction. We will respond within 48 hours with an NDA and, upon signing, access to the full data room.
Investor Relations
Detailed materials — including financial projections, cap table, and technical deep-dives — are available under NDA upon request.
Contact: hello@aikalab.se